Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression

Cell Reports

Volumn 7, Issue 4, 2014, Pages 1143-1155

  Kinsey, Conan ^a   Balakrishnan, Vijaya ^a   O'Dell, Michael R ^a   Huang, Jing Li ^a   Newman, Laurel ^a   Whitney Miller, Christa L ^a   Hezel, Aram F ^a   Land, Hartmut ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RAS PROTEIN; PLAC8 PROTEIN, HUMAN; PLAC8 PROTEIN, MOUSE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER GROWTH; CANCER INHIBITION; CANCER MODEL; CARCINOGENICITY; CELL FUSION; CELLULAR DISTRIBUTION; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; LYSOSOME; MOUSE; NONHUMAN; ONCOGENE RAS; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PLAC8 GENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ANIMAL CELL; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; GENE FUNCTION; HUMAN; HUMAN CELL; METABOLIC BALANCE; ONCOGENE; PANCREAS CANCER; ANIMAL; CELL DIFFERENTIATION; DISEASE COURSE; GENETICS; METABOLISM; MUTATION; NONOBESE DIABETIC MOUSE; NUDE MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROMOTER REGION; SCID MOUSE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; AUTOPHAGY; CARCINOMA, PANCREATIC DUCTAL; CELL DIFFERENTIATION; CELL LINE, TUMOR; DISEASE PROGRESSION; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED NOD; MICE, NUDE; MICE, SCID; MUTATION; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEINS;

EID: 84901271607     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.03.061     Document Type: Article

References (69)

1. Aguirre A.J., Bardeesy N., Sinha M., Lopez L., Tuveson D.A., Horner J., Redston M.S., DePinho R.A. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 2003, 17:3112-3126.
2. Ashton J.M., Balys M., Neering S.J., Hassane D.C., Cowley G., Root D.E., Miller P.G., Ebert B.L., McMurray H.R., Land H., Jordan C.T. Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells. Cell Stem Cell 2012, 11:359-372.
3. Balaburski G.M., Hontz R.D., Murphy M.E. p53 and ARF: unexpected players in autophagy. Trends Cell Biol. 2010, 20:363-369.
4. Bardeesy N., Aguirre A.J., Chu G.C., Cheng K.H., Lopez L.V., Hezel A.F., Feng B., Brennan C., Weissleder R., Mahmood U., et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc. Natl. Acad. Sci. USA 2006, 103:5947-5952.
5. Beertsen W., Willenborg M., Everts V., Zirogianni A., Podschun R., Schröder B., Eskelinen E.L., Saftig P. Impaired phagosomal maturation in neutrophils leads to periodontitis in lysosomal-associated membrane protein-2 knockout mice. J. Immunol. 2008, 180:475-482.
6. Biankin A.V., Waddell N., Kassahn K.S., Gingras M.C., Muthuswamy L.B., Johns A.L., Miller D.K., Wilson P.J., Patch A.M., Wu J., et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012, 491:399-405. Australian Pancreatic Cancer Genome Initiative.
7. Binker M.G., Cosen-Binker L.I., Terebiznik M.R., Mallo G.V., McCaw S.E., Eskelinen E.L., Willenborg M., Brumell J.H., Saftig P., Grinstein S., Gray-Owen S.D. Arrested maturation of Neisseria-containing phagosomes in the absence of the lysosome-associated membrane proteins, LAMP-1 and LAMP-2. Cell. Microbiol. 2007, 9:2153-2166.
8. Bucci C., Parton R.G., Mather I.H., Stunnenberg H., Simons K., Hoflack B., Zerial M. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 1992, 70:715-728.
9. Buchholz M., Braun M., Heidenblut A., Kestler H.A., Klöppel G., Schmiegel W., Hahn S.A., Lüttges J., Gress T.M. Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 2005, 24:6626-6636.
10. Chen X., Wang Z. Regulation of intracellular trafficking of the EGF receptor by Rab5 in the absence of phosphatidylinositol 3-kinase activity. EMBO Rep. 2001, 2:68-74.
11. Chen D., Fan W., Lu Y., Ding X., Chen S., Zhong Q. A mammalian autophagosome maturation mechanism mediated by TECPR1 and the Atg12-Atg5 conjugate. Mol. Cell 2012, 45:629-641.
12. Conroy T., Desseigne F., Ychou M., Bouché O., Guimbaud R., Bécouarn Y., Adenis A., Raoul J.L., Gourgou-Bourgade S., de la Fouchardière C., et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N. Engl. J. Med. 2011, 364:1817-1825. Groupe Tumeurs Digestives of Unicancer, PRODIGE IntergroupPRODIGE Intergroup.
13. DeNicola G.M., Karreth F.A., Humpton T.J., Gopinathan A., Wei C., Frese K., Mangal D., Yu K.H., Yeo C.J., Calhoun E.S., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011, 475:106-109.
14. Dinneen J.L., Ceresa B.P. Expression of dominant negative rab5 in HeLa cells regulates endocytic trafficking distal from the plasma membrane. Exp. Cell Res. 2004, 294:509-522.
15. Eskelinen E.L., Illert A.L., Tanaka Y., Schwarzmann G., Blanz J., Von Figura K., Saftig P. Role of LAMP-2 in lysosome biogenesis and autophagy. Mol. Biol. Cell 2002, 13:3355-3368.
16. Feng Z., Zhang H., Levine A.J., Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. USA 2005, 102:8204-8209.
17. Frese K.K., Neesse A., Cook N., Bapiro T.E., Lolkema M.P., Jodrell D.I., Tuveson D.A. nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. Cancer Discov. 2012, 2:260-269.
18. Furuta N., Fujita N., Noda T., Yoshimori T., Amano A. Combinational soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins VAMP8 and Vti1b mediate fusion of antimicrobial and canonical autophagosomes with lysosomes. Mol. Biol. Cell 2010, 21:1001-1010.
19. Galaviz-Hernandez C., Stagg C., de Ridder G., Tanaka T.S., Ko M.S., Schlessinger D., Nagaraja R. Plac8 and Plac9, novel placental-enriched genes identified through microarray analysis. Gene 2003, 309:81-89.
20. Ganley I.G., Wong P.M., Gammoh N., Jiang X. Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol. Cell 2011, 42:731-743.
21. Guo J.Y., Chen H.Y., Mathew R., Fan J., Strohecker A.M., Karsli-Uzunbas G., Kamphorst J.J., Chen G., Lemons J.M., Karantza V., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011, 25:460-470.
22. Gutierrez M.G., Munafó D.B., Berón W., Colombo M.I. Rab7 is required for the normal progression of the autophagic pathway in mammalian cells. J. Cell Sci. 2004, 117:2687-2697.
23. Hezel A.F., Kimmelman A.C., Stanger B.Z., Bardeesy N., Depinho R.A. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006, 20:1218-1249.
24. Hidalgo M. Pancreatic cancer. N. Engl. J. Med. 2010, 362:1605-1617.
25. Hingorani S.R., Petricoin E.F., Maitra A., Rajapakse V., King C., Jacobetz M.A., Ross S., Conrads T.P., Veenstra T.D., Hitt B.A., et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003, 4:437-450.
26. Hruban R.H., Iacobuzio-Donahue C., Wilentz R.E., Goggins M., Kern S.E. Molecular pathology of pancreatic cancer. Cancer J. 2001, 7:251-258.
27. Huynh K.K., Eskelinen E.L., Scott C.C., Malevanets A., Saftig P., Grinstein S. LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J. 2007, 26:313-324.
28. Jäger S., Bucci C., Tanida I., Ueno T., Kominami E., Saftig P., Eskelinen E.L. Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci. 2004, 117:4837-4848.
29. Jimenez-Preitner M., Berney X., Uldry M., Vitali A., Cinti S., Ledford J.G., Thorens B. Plac8 is an inducer of C/EBPβ required for brown fat differentiation, thermoregulation, and control of body weight. Cell Metab. 2011, 14:658-670.
30. Kimmelman A.C. The dynamic nature of autophagy in cancer. Genes Dev. 2011, 25:1999-2010.
31. Kimura S., Noda T., Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007, 3:452-460.
32. Klionsky D.J., Abeliovich H., Agostinis P., Agrawal D.K., Aliev G., Askew D.S., Baba M., Baehrecke E.H., Bahr B.A., Ballabio A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4:151-175.
33. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., Agholme L., Agnello M., Agostinis P., Aguirre-Ghiso J.A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
34. Komatsu M., Waguri S., Ueno T., Iwata J., Murata S., Tanida I., Ezaki J., Mizushima N., Ohsumi Y., Uchiyama Y., et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 2005, 169:425-434.
35. Kool J., Uren A.G., Martins C.P., Sie D., de Ridder J., Turner G., van Uitert M., Matentzoglu K., Lagcher W., Krimpenfort P., et al. Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypes. Cancer Res. 2010, 70:520-531.
36. Kuma A., Hatano M., Matsui M., Yamamoto A., Nakaya H., Yoshimori T., Ohsumi Y., Tokuhisa T., Mizushima N. The role of autophagy during the early neonatal starvation period. Nature 2004, 432:1032-1036.
37. Ledford J.G., Kovarova M., Koller B.H. Impaired host defense in mice lacking ONZIN. J. Immunol. 2007, 178:5132-5143.
38. Livesey K.M., Kang R., Vernon P., Buchser W., Loughran P., Watkins S.C., Zhang L., Manfredi J.J., Zeh H.J., Li L., et al. p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res. 2012, 72:1996-2005.
39. Lock R., Roy S., Kenific C.M., Su J.S., Salas E., Ronen S.M., Debnath J. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol. Cell 2011, 22:165-178.
40. Lowe A.W., Olsen M., Hao Y., Lee S.P., Taek Lee K., Chen X., van de Rijn M., Brown P.O. Gene expression patterns in pancreatic tumors, cells and tissues. PLoS ONE 2007, 2:e323.
41. Lüttges J., Galehdari H., Bröcker V., Schwarte-Waldhoff I., Henne-Bruns D., Klöppel G., Schmiegel W., Hahn S.A. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am. J. Pathol. 2001, 158:1677-1683.
42. McMurray H.R., Sampson E.R., Compitello G., Kinsey C., Newman L., Smith B., Chen S.R., Klebanov L., Salzman P., Yakovlev A., Land H. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature 2008, 453:1112-1116.
43. Mizushima N., Sugita H., Yoshimori T., Ohsumi Y. A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy. J. Biol. Chem. 1998, 273:33889-33892.
44. Mizushima N., Yamamoto A., Hatano M., Kobayashi Y., Kabeya Y., Suzuki K., Tokuhisa T., Ohsumi Y., Yoshimori T. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J. Cell Biol. 2001, 152:657-668.
45. Morselli E., Maiuri M.C., Markaki M., Megalou E., Pasparaki A., Palikaras K., Criollo A., Galluzzi L., Malik S.A., Vitale I., et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis. 2010, 1:e10.
46. Morselli E., Shen S., Ruckenstuhl C., Bauer M.A., Mariño G., Galluzzi L., Criollo A., Michaud M., Maiuri M.C., Chano T., et al. p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200. Cell Cycle 2011, 10:2763-2769.
47. N'Diaye E.N., Kajihara K.K., Hsieh I., Morisaki H., Debnath J., Brown E.J. PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep. 2009, 10:173-179.
48. O'Dell M.R., Huang J.L., Whitney-Miller C.L., Deshpande V., Rothberg P., Grose V., Rossi R.M., Zhu A.X., Land H., Bardeesy N., Hezel A.F. Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma. Cancer Res. 2012, 72:1557-1567.
49. Ogawa M., Yoshikawa Y., Kobayashi T., Mimuro H., Fukumatsu M., Kiga K., Piao Z., Ashida H., Yoshida M., Kakuta S., et al. A Tecpr1-dependent selective autophagy pathway targets bacterial pathogens. Cell Host Microbe 2011, 9:376-389.
50. Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat. Rev. Mol. Cell Biol. 2001, 2:211-216.
51. Olive K.P., Jacobetz M.A., Davidson C.J., Gopinathan A., McIntyre D., Honess D., Madhu B., Goldgraben M.A., Caldwell M.E., Allard D., et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461.
52. Pimkina J., Murphy M.E. ARF, autophagy and tumor suppression. Autophagy 2009, 5:397-399.
53. Provenzano P.P., Cuevas C., Chang A.E., Goel V.K., Von Hoff D.D., Hingorani S.R. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 2012, 21:418-429.
54. Rhim A.D., Mirek E.T., Aiello N.M., Maitra A., Bailey J.M., McAllister F., Reichert M., Beatty G.L., Rustgi A.K., Vonderheide R.H., et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148:349-361.
55. Rogulski K., Li Y., Rothermund K., Pu L., Watkins S., Yi F., Prochownik E.V. Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway. Oncogene 2005, 24:7524-7541.
56. Rosenfeldt M.T., O'Prey J., Morton J.P., Nixon C., MacKay G., Mrowinska A., Au A., Rai T.S., Zheng L., Ridgway R., et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 2013, 504:296-300.
57. Rubinstein A.D., Eisenstein M., Ber Y., Bialik S., Kimchi A. The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. Mol. Cell 2011, 44:698-709.
58. Smith B., Land H. Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep. 2012, 2:580-590.
59. Tanaka Y., Guhde G., Suter A., Eskelinen E.L., Hartmann D., Lüllmann-Rauch R., Janssen P.M., Blanz J., von Figura K., Saftig P. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 2000, 406:902-906.
60. Tanida I., Nishitani T., Nemoto T., Ueno T., Kominami E. Mammalian Apg12p, but not the Apg12p.Apg5p conjugate, facilitates LC3 processing. Biochem. Biophys. Res. Commun. 2002, 296:1164-1170.
61. Tasdemir E., Maiuri M.C., Galluzzi L., Vitale I., Djavaheri-Mergny M., D'Amelio M., Criollo A., Morselli E., Zhu C., Harper F., et al. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 2008, 10:676-687.
62. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 2012, 12:401-410.
63. Williams G.T., Hughes J.P., Stoneman V., Anderson C.L., McCarthy N.J., Mourtada-Maarabouni M., Pickard M., Hedge V.L., Trayner I., Farzaneh F. Isolation of genes controlling apoptosis through their effects on cell survival. Gene Ther. Mol. Biol. 2006, 10(B):255-262.
64. Wong S.H., Zhang T., Xu Y., Subramaniam V.N., Griffiths G., Hong W. Endobrevin, a novel synaptobrevin/VAMP-like protein preferentially associated with the early endosome. Mol. Biol. Cell 1998, 9:1549-1563.
65. Wu S.F., Huang Y., Hou J.K., Yuan T.T., Zhou C.X., Zhang J., Chen G.Q. The downregulation of onzin expression by PKCepsilon-ERK2 signaling and its potential role in AML cell differentiation. Leukemia 2010, 24:544-551.
66. Xia M., Land H. Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat. Struct. Mol. Biol. 2007, 14:215-223.
67. Yamamoto A., Tagawa Y., Yoshimori T., Moriyama Y., Masaki R., Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 1998, 23:33-42.
68. Yang S., Wang X., Contino G., Liesa M., Sahin E., Ying H., Bause A., Li Y., Stommel J.M., Dell'antonio G., et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011, 25:717-729.
69. Ying H., Kimmelman A.C., Lyssiotis C.A., Hua S., Chu G.C., Fletcher-Sananikone E., Locasale J.W., Son J., Zhang H., Coloff J.L., et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 2012, 149:656-670.